Brief: Marksans Pharma March-Qtr Consol Net Profit Falls
30/05/2024 07:26
May 30 (Reuters) - Marksans Pharma Ltd MARK.NS :
* MARKSANS PHARMA MARCH-QUARTER CONSOL NET PROFIT 782.9
MILLION
RUPEES VERSUS PROFIT 819.3 MILLION RUPEES
* MARKSANS PHARMA MARCH-QUARTER CONSOL REVENUE FROM
OPERATIONS 5.6
BILLION RUPEES VERSUS 4.86 BILLION RUPEES
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg